JPMA Issues Statement Calling for IP Protection, Expresses Concerns over Issuance of Compulsory Licenses

The Japan Pharmaceutical Manufacturers Association (JPMA) issued on February 5 a statement appealing for the protection of intellectual property (IP) for pharmaceutical products. Citing the example of the issuance of compulsory licenses that grant the use of technology protected by...read more